Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-12-30
2008-12-16
Yu, Misook (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C436S501000, C436S518000
Reexamination Certificate
active
07465553
ABSTRACT:
The invention features methods of diagnosing high grade ductal carcinoma in situ (DCIS) These methods involve measuring: (1) the level of HID-5 in a body fluid (e.g., blood or urine) of a subject suspected of having, or at risk of having, high grade DCIS; or (2) the level of HID-5 gene expression in breast tissue from a subject suspected of having, or at risk of having, high grade DCIS. The invention also embodies a method of inhibiting expression of HID-5 protein in DCIS cells and methods of treating a subject suspected of having, or at risk of having, high grade DCIS.
REFERENCES:
patent: WO 00/26668 (2000-05-01), None
patent: WO 00/55629 (2000-09-01), None
patent: WO 01/87238 (2001-11-01), None
Filella et al. Prostate-specific antigen detection by ultrasensitive assay in sample from women. Dec. 1999. Prostate 29(5):311-316.
Hillebrand et al. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplaysia and prostate cancer. Nov.-Dec. 2000. Anticancer Research 20(6D):4995-6.
Al-Haddad et al. Psoriasin (S100A7) expression and invasive breast cancer. Dec. 1999. American Journal of Pathology 155(6):2057-2066.
Leygue et al., “Differential Expression of Psoriasin Messenger RNA between in Situ and Invasive Human Breast Carcinoma”, Cancer Res. 56:4606-4609 (1996).
Porter et al., “A SAGE (Serial Analysis of Gene Expression) View of Breast Tumor Progression”, Cancer Res. 61:5697-5702 (2001).
Watson et al., “Molecules in focus Psoriasin (S100A7)”, Intl. J. Biochem & Cell Biol. 30:567-571 (1998).
Al-Haddad et al., “Psoriasin (S100A7) expression and invasive breast cancer”, The Am. J. Pathol., 155(6):2057-2066 (Dec. 1999).
Fisher et al., “Pathologic Findings from the national Surgical Adjuvant Breast Project (NSABP) Eight-Year Update of Protocol B-17”, Cancer, 86(3):429-438 (1999).
Cancer Topics: Ductal Carcinoma In Situ, Website of the National Cancer institute of the U.S. National Instututes of Health (http://www.cacer.gov/cancertopics/pdq/treatment/breast/HealthProfessional/page5).
Enerbäck Charlotta
Polyak Kornelia
Dana-Farber Cancer Institute Inc.
Fish & Richardson P.C.
Yu Misook
LandOfFree
Psoriasin expression by breast epithelial cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psoriasin expression by breast epithelial cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psoriasin expression by breast epithelial cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4021879